Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Recent advances in Japanese encephalitis.

Tom Solomon1

  • 1Departments of Neurological Science and Medical Microbiology, University of Liverpool, Liverpool, United Kingdom. tsolomon@liv.ac.uk

Journal of Neurovirology
|April 23, 2003
PubMed
Summary

Japanese encephalitis (JE) is a significant global encephalitis. Current vaccines are limited by cost or regulatory issues, and no effective antiviral treatments exist for JE.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Adjunct dexamethasone in herpes simplex virus encephalitis - Authors' reply.

The Lancet. Neurology·2026
Same author

Safety and efficacy of adjunct dexamethasone in adults with herpes simplex virus encephalitis in the UK (DexEnceph): a multicentre, observer-blind, randomised, phase 3, controlled trial.

The Lancet. Neurology·2026
Same author

International evaluation of the SEIZUre Risk in Encephalitis (SEIZURE) score for predicting acute seizure risk.

BMJ open·2025
Same author

Global & Community Health: What Did the COVID-19 Pandemic Teach Us About Neurologic Surveillance Approaches, and How Should We Be Better Prepared?

Neurology·2025
Same author

Correction: Neurologic symptoms following COVID-19 in Lima, Peru: a prospective longitudinal observational study.

Frontiers in neurology·2025
Same author

Viral Infection and the Blood-Brain Barrier: Molecular Research Insights and Therapies.

The Journal of infectious diseases·2025

Area of Science:

  • Virology
  • Neuroscience
  • Epidemiology

Background:

  • Japanese encephalitis (JE) is a leading cause of epidemic encephalitis globally, primarily affecting Asia but with a spreading geographical range.
  • Related flaviviruses, such as West Nile virus, cause similar neurological diseases in other regions.
  • Cryoelectron microscopy has revealed the flavivirus envelope protein as a novel viral fusion protein (class II).

Purpose of the Study:

  • To review the current understanding of Japanese encephalitis, including its virology, clinical presentation, and management.
  • To discuss the limitations and ongoing development of vaccines against JE.
  • To evaluate the efficacy of antiviral treatments for JE.

Main Methods:

  • Literature review of recent studies on Japanese encephalitis.
  • Analysis of cryoelectron microscopy data on flavivirus structure.
  • Examination of clinical presentations and outcomes in JE patients.
  • Assessment of vaccine efficacy and safety data.
  • Review of clinical trial results for antiviral therapies.

Main Results:

  • Alterations in the flavivirus envelope protein's hinge or receptor-binding domains correlate with neurovirulence in JE animal models.
  • JE presents with diverse neurological symptoms, including flaccid paralysis, seizures, and increased intracranial pressure, impacting patient outcomes.
  • Existing JE vaccines face challenges with cost and regulatory approval, while new vaccine candidates are under development.
  • Interferon alpha has shown no significant benefit in treating JE in children, despite earlier promising results.

Conclusions:

  • Japanese encephalitis remains a significant public health challenge with limited treatment options.
  • Development of cost-effective and accessible vaccines is crucial for controlling JE outbreaks.
  • Further research into effective antiviral therapies for JE is warranted.

Related Experiment Videos